Swedish Orphan (Sweden) Buy Hold or Sell Recommendation

SOBI Stock  SEK 307.80  6.60  2.19%   
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Swedish Orphan Biovitrum is 'Cautious Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Swedish Orphan Biovitrum given historical horizon and risk tolerance towards Swedish Orphan. When Macroaxis issues a 'buy' or 'sell' recommendation for Swedish Orphan Biovitrum, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Swedish Orphan Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note, we conduct extensive research on individual companies such as Swedish and provide practical buy, sell, or hold advice based on investors' constraints. Swedish Orphan Biovitrum. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Execute Swedish Orphan Buy or Sell Advice

The Swedish recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Swedish Orphan Biovitrum. Macroaxis does not own or have any residual interests in Swedish Orphan Biovitrum or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Swedish Orphan's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Swedish OrphanBuy Swedish Orphan
Cautious Hold

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Slowly supersedes the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Swedish Orphan Biovitrum has a Mean Deviation of 1.34, Standard Deviation of 2.12 and Variance of 4.48
Macroaxis provides recommendation on Swedish Orphan Biovitrum to complement and cross-verify current analyst consensus on Swedish Orphan Biovitrum. Our trade recommendation engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Swedish Orphan Biovitrum is not overpriced, please validate all Swedish Orphan fundamentals, including its shares owned by insiders, price to earning, and the relationship between the shares outstanding and shares owned by institutions .

Swedish Orphan Trading Alerts and Improvement Suggestions

Swedish Orphan generated a negative expected return over the last 90 days
Swedish Orphan Biovitrum has accumulated 9.02 B in total debt with debt to equity ratio (D/E) of 39.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Swedish Orphan Biovitrum has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Swedish Orphan until it has trouble settling it off, either with new capital or with free cash flow. So, Swedish Orphan's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Swedish Orphan Biovitrum sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Swedish to invest in growth at high rates of return. When we think about Swedish Orphan's use of debt, we should always consider it together with cash and equity.
About 71.0% of Swedish Orphan shares are owned by institutional investors

Swedish Orphan Returns Distribution Density

The distribution of Swedish Orphan's historical returns is an attempt to chart the uncertainty of Swedish Orphan's future price movements. The chart of the probability distribution of Swedish Orphan daily returns describes the distribution of returns around its average expected value. We use Swedish Orphan Biovitrum price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Swedish Orphan returns is essential to provide solid investment advice for Swedish Orphan.
Mean Return
-0.05
Value At Risk
-2.68
Potential Upside
2.97
Standard Deviation
2.12
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Swedish Orphan historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Swedish Orphan Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Swedish Orphan or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Swedish Orphan's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Swedish stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
-0.09
β
Beta against Dow Jones0.30
σ
Overall volatility
2.15
Ir
Information ratio -0.08

Swedish Orphan Volatility Alert

Swedish Orphan Biovitrum exhibits very low volatility with skewness of -1.57 and kurtosis of 7.91. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Swedish Orphan's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Swedish Orphan's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Swedish Orphan Fundamentals Vs Peers

Comparing Swedish Orphan's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Swedish Orphan's direct or indirect competition across all of the common fundamentals between Swedish Orphan and the related equities. This way, we can detect undervalued stocks with similar characteristics as Swedish Orphan or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Swedish Orphan's fundamental indicators could also be used in its relative valuation, which is a method of valuing Swedish Orphan by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Swedish Orphan to competition
FundamentalsSwedish OrphanPeer Average
Return On Equity0.11-0.31
Return On Asset0.0555-0.14
Profit Margin0.14 %(1.27) %
Operating Margin0.24 %(5.51) %
Current Valuation72.79 B16.62 B
Shares Outstanding295.99 M571.82 M
Shares Owned By Insiders4.00 %10.09 %
Shares Owned By Institutions70.55 %39.21 %
Price To Earning20.29 X28.72 X
Price To Book2.51 X9.51 X
Price To Sales3.67 X11.42 X
Revenue15.53 B9.43 B
Gross Profit14.38 B27.38 B
EBITDA5.72 B3.9 B
Net Income2.68 B570.98 M
Cash And Equivalents1.04 B2.7 B
Cash Per Share4.04 X5.01 X
Total Debt9.02 B5.32 B
Debt To Equity39.80 %48.70 %
Current Ratio0.75 X2.16 X
Book Value Per Share89.61 X1.93 K
Cash Flow From Operations5.47 B971.22 M
Earnings Per Share10.10 X3.12 X
Price To Earnings To Growth1.98 X4.89 X
Target Price269.56
Number Of Employees1.56 K18.84 K
Beta0.39-0.15
Market Capitalization73.08 B19.03 B
Total Asset48.66 B29.47 B
Working Capital1.42 B1.48 B
Current Asset2.68 B9.34 B
Current Liabilities1.26 B7.9 B
Z Score4.88.72

Swedish Orphan Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Swedish . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Swedish Orphan Buy or Sell Advice

When is the right time to buy or sell Swedish Orphan Biovitrum? Buying financial instruments such as Swedish Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Swedish Orphan in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Furniture Thematic Idea Now

Furniture
Furniture Theme
Companies producing and selling home and office furniture. The Furniture theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Furniture Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Swedish Stock Analysis

When running Swedish Orphan's price analysis, check to measure Swedish Orphan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Swedish Orphan is operating at the current time. Most of Swedish Orphan's value examination focuses on studying past and present price action to predict the probability of Swedish Orphan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Swedish Orphan's price. Additionally, you may evaluate how the addition of Swedish Orphan to your portfolios can decrease your overall portfolio volatility.